Latest Hydrocodone Stories
DEA’s announcement comes after a recommendation last year concerning the potent combination drug products. Port Washington, New York (PRWEB) August 29, 2014
Controversial Hydrocodone-Based Painkiller Zohydro contains strong potential for addiction and as a substitute for OxyContin and heroin abuse.
A decade-long effort in genetic engineering is close to creating yeast that makes palliative medicines in stainless steel vats.
Daiichi Sankyo and Charleston Laboratories will collaborate on development and commercialization; Charleston will supply all products and retain an option to co-promote in the United States
CR urges U.S.
WAYNE, Pa., July 29, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its second quarter financial results will be released on Tuesday, August 12, 2014.
Anticipated FDA action set for October 2014 STAMFORD, Conn., July 8, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S.
Multi-Tranche Financing Provides Sufficient Funding to Take KP201 Through and Beyond Potential FDA Approval and Enables KemPharm to Advance its Full Pipeline of Abuse-Deterrent Prodrugs
Controlled Substance Analgesic Combination Product Uses Depomed's Proprietary Acuform® Technology NEWARK, Calif., May 28, 2014 /PRNewswire/ -- Depomed, Inc.
CutisPharma has moved to a larger facility to support growth WILMINGTON, Mass., May 21, 2014 /PRNewswire/ -- CutisPharma, Inc.
- Withering but not falling off, as a blossom that persists on a twig after flowering.